Cost-effectiveness analysis of routine pediatric vaccination of 15-valent pneumococcal conjugate vaccine in South Korea

Pneumococcal disease poses a substantial clinical and economic burden, especially among children under 5 years old. The 13-valent pneumococcal conjugate vaccine (PCV13) was first introduced in South Korea’s Childhood Immunization Program in 2014. In October 2023, the Ministry of Food and Drug Safety...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Young June Choe, Yunjin Jeon, Jihyun Park, Hyesun Kim, Gyongseon Yang, Salini Mohanty, Lefteris Floros, Min Huang, Nitika Chhabra, Shalini Kumari, Jasmeet Singh, Isaya Sukarom
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis Group 2025-12-01
Серии:Human Vaccines & Immunotherapeutics
Предметы:
Invasive pneumococcal disease
Streptococcus pneumoniae
bacteremic pneumococcal pneumonia
acute otitis media
Online-ссылка:https://www.tandfonline.com/doi/10.1080/21645515.2025.2515650
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы